Prophylaxis of postoperative endophthalmitis following cataract surgery: Current status and future directions

Drugs

Volumn 70, Issue 11, 2010, Pages 1395-1409

  Fintelmann, Robert E ^a,b   Naseri, Ayman ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cefuroxime, therapeutic use; cephalosporins, therapeutic use; endophthalmitis, prevention; endophthalmitis, treatment; fluoroquinolones, therapeutic use; povidone iodine, therapeutic use; topical

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; COLLAGEN; COLLAGEN SHIELD; DEXAMETHASONE; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; CATARACT EXTRACTION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; ENDOPHTHALMITIS; EYE TOXICITY; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK FACTOR; VITRECTOMY; AGING; ANTIBIOTIC PROPHYLAXIS; ECONOMICS; FORECASTING; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

POSIBACTERIA;

AGING; ANTIBIOTIC PROPHYLAXIS; CATARACT EXTRACTION; ENDOPHTHALMITIS; FORECASTING; HUMANS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 77954551381     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11537950-000000000-00000     Document Type: Review

References (78)

1. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina 2007 Jul-Aug; 27 (6): 662-680
2. Lalwani GA, Flynn Jr HW, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005): clinical features, causative organisms, and visual acuity outcomes. Ophthalmology 2008 Mar; 115 (3): 473-476
3. Kutty PK, Forster TS, Wood-Koob C, et al. Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg 2008 Apr; 34 (4): 585-590
4. Results of the Endophthalmitis Vitrectomy Study: a ran-domized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial en-dophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995 Dec; 113(12): 1479-1496
5. Erie JC, Baratz KH, Hodge DO, et al. Incidence of cataract surgery from 1980 through 2004: 25-year population-based study. J Cataract Refract Surg 2007 Jul; 33 (7): 1273-1277
6. Norregaard JC, Hindsberger C, Alonso J, et al. Visual out-comes of cataract surgery in the United States, Canada, Denmark, and Spain: report from the International Cataract Surgery Outcomes Study. Arch Ophthalmol 1998 Aug; 116 (8): 1095-1100
7. Murthy GV, Vashist P, John N, et al. Prevalence and vision-related outcomes of cataract surgery in Gujarat, India. Ophthalmic Epidemiol 2009 Nov-Dec; 16 (6): 400-409
8. Nemet AY, Nemet P, Cohn G, et al. Causes of blindness in rural Myanmar (Burma): Mount Popa Taung-Kalat Blindness Prevention Project. Clin Ophthalmol 2009; 3: 413-421
9. Song W, Sun X, Shao Z, et al. Prevalence and causes of visual impairment in a rural North-east China adult population: a population-based survey in Bin County, Harbin. Acta Ophthalmol. Epub 2009 Nov 7
10. Tabin G, Chen M, Espandar L. Cataract surgery for the developing world. Curr Opin Ophthalmol 2008 Jan; 19 (1): 55-59
11. West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 2005 Aug; 112 (8): 1388-1394
12. Hatch WV, Cernat G, Wong D, et al. Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology 2009 Mar; 116 (3): 425-430
13. Endophthalmitis Study Group, European Society of Catar-act & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007 Jun; 33 (6): 978-988
14. Freeman EE, Roy-Gagnon MH, Fortin E, et al. Rate of endophthalmitis after cataract surgery in Quebec, Canada, 1996-2005. Arch Ophthalmol 2010 Feb; 128 (2): 230-234
15. Wong TY, Chee SP. The epidemiology of acute en-dophthalmitis after cataract surgery in an Asian population. Ophthalmology 2004 Apr; 111 (4): 699-705
16. Ravindran RD, Venkatesh R, Chang DF, et al. Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg 2009 Apr; 35 (4): 629-636
17. Al-Mezaine HS, Kangave D, Al-Assiri A, et al. Acute-onset nosocomial endophthalmitis after cataract surgery: incidence, clinical features, causative organisms, and visual outcomes. J Cataract Refract Surg 2009 Apr; 35 (4): 643-649
18. Taban M, Behrens A, Newcomb RL, et al. Acute en-dophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 2005 May; 123 (5): 613-620 (Pubitemid 40695508)
19. Carrim ZI, Richardson J, Wykes WN. Incidence and visual outcome of acute endophthalmitis after cataract surgery: the experience of an eye department in Scotland. Br J Ophthalmol 2009 Jun; 93 (6): 721-725
20. Deramo VA, Lai JC, Fastenberg DM, et al. Acute en-dophthalmitis in eyes treated prophylactically with gati-floxacin and moxifloxacin. Am J Ophthalmol 2006 Nov; 142 (5): 721-725
21. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the En-dophthalmitis Vitrectomy Study. Am J Ophthalmol 1996 Jul; 122 (1): 1-17
22. Montan P, Lundstrom M, Stenevi U, et al. Endophthalmitis following cataract surgery in Sweden: the 1998 national prospective survey. Acta Ophthalmol Scand 2002 Jun; 80 (3): 258-261
23. Wejde G, Montan P, Lundstrom M, et al. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol Scand 2005 Feb; 83 (1): 7-10
24. Pijl BJ, Theelen T, Tilanus MA, et al. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Am J Ophthal-mol 2010 Mar; 149 (3): 482-7.e1-2
25. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial en-dophthalmitis after small-incision cataract surgery: effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003 Jan; 29 (1): 20-26
26. McDonnell PJ, Taban M, Sarayba M, et al. Dynamic mor-phology of clear corneal cataract incisions. Ophthalmology 2003 Dec; 110 (12): 2342-2348
27. Herretes S, Stark WJ, Pirouzmanesh A, et al. Inflow of ocular surface fluid into the anterior chamber after pha-coemulsification through sutureless corneal cataract wounds. Am J Ophthalmol 2005 Oct; 140 (4): 737-740
28. Sarayba MA, Taban M, Ignacio TS, et al. Inflow of ocular surface fluid through clear corneal cataract incisions: a laboratory model. Am J Ophthalmol 2004 Aug; 138 (2): 206-210
29. Kodjikian L, Beby F, Rabilloud M, et al. Influence of intraocular lens material on the development of acute en-dophthalmitis after cataract surgery? Eye (Lond) 2008 Feb; 22 (2): 184-193
30. Wallin T, Parker J, Jin Y, et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg 2005 Apr; 31 (4): 735-741
31. Lundstrom M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007 May; 114 (5): 866-870
32. Kamalarajah S, Ling R, Silvestri G, et al. Presumed in-fectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye (Lond) 2007 May; 21 (5): 580-586
33. Menikoff JA, Speaker MG, Marmor M, et al. A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology 1991 Dec; 98 (12): 1761-1768
34. Ng JQ, Morlet N, Bulsara MK, et al. Reducing the risk for endophthalmitis after cataract surgery: population-based nested case-control study: endophthalmitis population study of Western Australia sixth report. J Cataract Refract Surg 2007 Feb; 33 (2): 269-280
35. Doft BH. Treatment of postcataract extraction en-dophthalmitis: a summary of the results from the En-dophthalmitis Vitrectomy Study. Arch Ophthalmol 2008 Apr; 126 (4): 554-556
36. Kuhn F, Gini G. Ten years aftery are findings of the En-dophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol 2005 Dec; 243 (12): 1197-1199
37. Altan T, Acar N, Kapran Z, et al. Acute-onset en-dophthalmitis after cataract surgery: success of initial therapy, visual outcomes, and related factors. Retina 2009 May; 29 (5): 606-612
38. Miller JJ, Scott IU, Flynn Jr HW. Acute-onset en-dophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005 Jun; 139 (6): 983-987
39. Romero P, Mendez I, Salvat M, et al. Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery. J Cataract Refract Surg 2006 Mar; 32 (3): 438-441
40. Garat M, Moser CL, Alonso-Tarres C, et al. Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study. J Cataract Refract Surg 2005 Nov; 31 (11): 2230-2234
41. Mollan SP, Gao A, Lockwood A, et al. Postcataract en-dophthalmitis: incidence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg 2007 Feb; 33 (2): 265-268
42. Montan PG, Wejde G, Koranyi G, et al. Prophylactic intra-cameral cefuroxime: efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2002 Jun; 28 (6): 977-981
43. Garat M, Moser CL, Martin-Baranera M, et al. Prophy-lactic intracameral cefazolin after cataract surgery: en-dophthalmitis risk reduction and safety results in a 6-year study. J Cataract Refract Surg 2009 Apr; 35 (4): 637-642
44. Carrim ZI, Mackie G, Gallacher G, et al. The efficacy of 5% povidone-iodine for 3 minutes prior to cataract surgery. Eur J Ophthalmol 2009 Jul-Aug; 19 (4): 560-564
45. Inoue Y, Usui M, Ohashi Y, et al. Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study. Jpn J Ophthalmol 2008 May-Jun; 52 (3): 151-161
46. Wu PC, Li M, Chang SJ, et al. Risk of endophthalmitis after cataract surgery using different protocols for povidone-iodine preoperative disinfection. J Ocul Pharmacol Ther 2006 Feb; 22 (1): 54-61
47. Darouiche RO, Wall Jr MJ, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010 Jan 7; 362 (1): 18-26
48. Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg 2007 Oct; 33 (10): 1801-1805
49. Moss JM, Nguyen D, Liu YI, et al. Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora. Ophthalmology 2008 Nov; 115 (11): 2013-2016
50. Katz HR, Masket S, Lane SS, et al. Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea 2005 Nov; 24 (8): 955-958
51. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J Cataract Refract Surg 2007 Jan;33 (1): 59-62
52. McCulley JP, Caudle D, Aronowicz JD, et al. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology 2006 Jun; 113 (6): 955-959
53. Kowalski RP, Romanowski EG, Mah FS, et al. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol 2004 Jul; 138 (1): 33-37
54. Moshirfar M, Feiz V, Vitale AT, et al. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology 2007 Apr; 114 (4): 686-691
55. Jensen MK, Fiscella RG, Moshirfar M, et al. Third-and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg 2008 Sep;34 (9): 1460-1467
56. Colleaux KM, Hamilton WK. Effect of prophylactic anti-biotics and incision type on the incidence of en-dophthalmitis after cataract surgery. Can J Ophthalmol 2000 Dec; 35 (7): 373-378
57. Clements DB, Tailor V. A study of aqueous and serum levels of ceftazidime following subconjunctival administration. Br J Ophthalmol 1987 Jun; 71 (6): 433-435
58. Souli M, Kopsinis G, Kavouklis E, et al. Vancomycin levels in human aqueous humour after intravenous and sub-conjunctival administration. Int J Antimicrob Agents 2001 Sep; 18 (3): 239-243
59. Barza M, Doft B, Lynch E. Ocular penetration of ceftriax-one, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol 1993 Apr; 111 (4): 492-494
60. Menchini U, Lanzetta P, Ferrari E, et al. Efficacy of collagen shields after extracapsular cataract extraction. Eur J Oph-thalmol 1994 Jul-Sep; 4 (3): 175-180
61. Renard G, Bennani N, Lutaj P, et al. Comparative study of a collagen corneal shield and a subconjunctival injection at the end of cataract surgery. J Cataract Refract Surg 1993 Jan; 19 (1): 48-51
62. Taravella MJ, Balentine J, Young DA, et al. Collagen shield delivery of ofloxacin to the human eye. J Cataract Refract Surg 1999 Apr; 25 (4): 562-565
63. Peyman GA, Sathar ML, May DR. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol 1977 Apr; 61 (4): 260-262
64. Gimbel HV, Sun R, DeBrof BM. Prophylactic intracameral antibiotics during cataract surgery: the incidence of en-dophthalmitis and corneal endothelial cell loss. Eur J Implant Ref Surg 1994 Oct; 6: 280-285
65. Garc?a-Saenz MC, Arias-Puente A, Rodr?guez-Caravaca G, et al. Effectiveness of intracameral cefuroxime in prevent-ing endophthalmitis after cataract surgery. J Cataract Refract Surg 2010 Feb; 36 (2): 203-207
66. Arbisser LB. Safety of intracameral moxifloxacin for pro-phylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg 2008 Jul; 34 (7): 1114-1120
67. Espiritu CR, Caparas VL, Bolinao JG. Safety of prophy-lactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 2007 Jan; 33 (1): 63-68
68. Lane SS, Osher RH, Masket S, et al. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg 2008 Sep; 34 (9): 1451-1459
69. Kowalski RP, Romanowski EG, Mah FS, et al. In-tracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 2005 Sep; 140 (3): 497-504
70. Kodjikian L, Garweg JG. Intracameral Vigamox (moxi-floxacin 0.5%) is not effective in preventing en-dophthalmitis in a rabbit model [letter]. Am J Ophthalmol 2006 Apr; 141 (4): 777
71. Kowalski RP, Romanowski EG, Mah FS, et al. Reply: in-tracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model [letter]. Am J Ophthalmol 2006 Apr; 141 (4): 7778
72. Major Jr JC, Engelbert M, Flynn Jr HW, et al. Staphylo-coccus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Oph-thalmol 2010 Feb; 149 (2): 278-83.e1
73. Sharifi E, Porco T, Naseri A. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of en-dophthalmitis following cataract surgery. Ophthalmology 2009 Oct; 116 (10): 1887-1896
74. Gore DM, Angunawela RI, Little BC. United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. J Cataract Refract Surg 2009 Apr; 35 (4): 770-773
75. Mamalis N. Toxic anterior segment syndrome. J Cataract Refract Surg 2006 Feb; 32 (2): 181-182
76. Liu DT, Lee VY, Chan VC, et al. Severe anaphylactic reac-tion after intracameral antibiotic administration during cataract surgery [letter]. J Cataract Refract Surg 2006 Feb; 32 (2): 188
77. Alio JL. Reply: severe anaphylactic reaction after intra-cameral antibiotic administration during cataract surgery [letter]. J Cataract Refract Surg 2006 Feb; 32 (2): 188
78. Asbell PA, Colby KA, Deng S, et al. Ocular TRUST: na-tionwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol 2008 Jun; 145 (6): 951-8